Innate Pharma SA: Innate Pharma Announces Its Participation

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced members of its executive team are scheduled to participate in the upcoming conferences

Related Keywords

France , United States , Rockville , New York , Miami , Florida , French , Arthur Rouill , Sonia Quaratino , Henry Wheeler , Euronext , Linkedin , French Financial Markets Authority , Nasdaq , Exchange Commission , Goldman Sachs , Astrazeneca , Company Annual Report On Form , Regulatory News , Euronext Paris , Chief Executive Officer , Executive Vice President , Chief Medical Officer , Yannis Morel , Chief Operating Officer , Arvind Sood , Global Healthcare Conference , Annual Global Healthcare Conference , Annual Immune Cell Engager Virtual Conference , European Healthcare Summit Lyon , Engager Therapeutics , Innate Pharma , Private Securities Litigation Reform Act , Risk Factors , Universal Registration Document , Annual Report , Ihr Portfolio ,